As organizations in the life sciences industry look to opportunities to generate greater returns and increase efficiencies, there’s a growing interest in AI-driven R&D processes among other aspects of the value chain. Netscribes research shows that this trend continues to pick up the pace, with AI startups in life sciences R&D attracting a record funding of USD 2.5B in the first half of 2021 alone.
Based on our in-house research expertise, we’ve put together key data and information to give you an overview of where these AI-driven startups in life sciences R&D are headed. Download this infographic to find out:
- The need for AI in life sciences R&D
- How life sciences R&D can benefit from AI
- Funding trends over the last seven years (2015-2021)
- Global investment contribution and forecasted investment growth of AI startups in life sciences R&D
- Best-funded AI startups in this space
- Funding by therapeutic areas
- Funding by application areas
For more information and strategic insight into the current state of the life sciences and healthcare industry and future market trends, contact us.